Wilson Therapeutics Appoints Andrew Kay as Chairman

STOCKHOLM, Oct. 20, 2015 -- (Healthcare Sales & Marketing Network) -- Wilson Therapeutics AB, a privately-held biopharmaceutical company, today announced that Andrew Kay has been appointed as Chairman of its Board of Directors. The company's previous Cha... Biopharmaceuticals, PersonnelWilson Therapeutics, Wilson's Disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news